Redesign Health launched a dedicated Growth Equity practice on November 13, 2026. The new team will make minority investments from Series A through pre-IPO. Redesign Health operates as a global healthcare technology company.
Investment focus
The practice will target healthcare IT, AI-enabled services, and clinical AI. It will focus on companies that already have customers, revenue, and product-market fit. The strategy complements the firm's Seed and venture buyout practices.
Team additions
Richie Chaikof joined Redesign Health as Managing Director, Growth Equity. He brings experience from Optum Ventures and Bain Capital Ventures. Akhilesh Pathipati, a physician and former MVM partner, also joined the team.
Broader platform reach
The practice draws on Redesign Health's relationships across health systems, health plans, and providers. The firm merged with ARC Global in October and agreed to acquire AVIA. Those moves connect Redesign Health to more than 100 health systems worldwide.
Founders and co-investors can reach the Growth Equity team by email. The practice already counts Hippocratic AI among its opportunistic growth-stage investments. The firm has invested in healthcare companies since its founding in 2018.